Molekulardiagnostik

PHOENIXDX® SARS-COV-2 MULTIPLEX IVD ist ein in-vitro Diagnostik Test zum Nachweis viraler 2019- Novel Coronavirus (SARS-CoV-2) RNA aus Proben aus dem Respirationstrakt von Patienten, die den klinischen und/oder epidemiologischen Kriterien entsprechen.

PHOENIXDX® COFLUENZA 4-PLEX IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of Influenza A, Influenza B and SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [N501Y] is a real-time RT-PCR-based diagnostic test for the in vitro discrimination between wildtype SARS-CoV-2 and N501Y mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of 2019-Novel Coronavirus (SARS-CoV-2) in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

PHOENIXDX® SARS-COV-2 N501Y MULTIPLEX is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2 and the N501Y mutant in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

Adellgene Fragile X Screening is a diagnostic kit designed for use in laboratories, which detects the number of CGG triplet repeats (cytosine-guanine-guanine) in the 5’ untranslated region of the gene for fragile X mental retardation (“Fragile X mental retardation-1”: FMR1). It aims to aid diagnosis of the clinical disease associated with Fragile X syndrome, for example, mental retardation, primary ovarian failure, and tremors / ataxia.

Adellgene Huntington Disease (HD) is an in vitro diagnostic kit designed for use in clinical laboratories. The kit detects the number of repetitions of the CAG (cytosine-adenine-guanine) triplet, located on exon 1 of the IT15 gene (HTT), which can result in the formation of Huntington’s disease, also called Huntington’s Chorea. It aims to aid the clinical diagnosis associated with Huntington’s chorea, such as: subtle changes in coordination, involuntary minor movements, difficulty mentally planning, and often a depressed or irritable mood.

Adellgene® Myotonic Dystrophy Screening is a kit designed for use in clinical laboratories which detects the number of repetitions of CTG of 3´UTR region of the DMPK gene located in chromosome 19 resulting in Myotonic Dystrophy disease. It aims to aid clinical diagnosis associated with clinical findings in myotonic dystrophy type 1 (DM1) that span from mild to severe symptoms.

Adellgene® Myotonic Dystrophy Confirmatory is a kit designed for use in clinical laboratories which detects the number of repetitions of CTG of 3´UTR region of the DMPK gene located in chromosome 19 resulting in Myotonic Dystrophy disease. It aims to aid clinical diagnosis associated with clinical findings in myotonic dystrophy type 1 (DM1) that span from mild to severe symptoms.